Testosterone replacement therapy: who it helps, who it doesn't, and how it should be done.

Men rarely research testosterone replacement therapy out of curiosity. It usually starts after months or years of something being off — fatigue, low libido, workouts that stopped working, a waistline that keeps growing, a mood that flattened. "Low T" is one plausible explanation, and an entire industry now exists to sell it as the only one.

TRT properly means replacing testosterone in men with deficiency and returning levels to a physiologic range. Testosterone may also be considered in other circumstances through an informed, individualized discussion, but goals, expected exposure, and uncertainty should be named honestly rather than relabeling supraphysiologic use as "TRT." Done casually, testosterone can suppress fertility, raise red blood cell counts, worsen untreated sleep apnea, and miss the actual cause of the symptoms. The evaluation and longitudinal follow-up matter as much as the prescription.

What testosterone replacement therapy is

TRT is the medical use of testosterone to restore levels in men with clinically significant deficiency. FDA-approved options include injections, daily gels, patches, nasal gel, oral formulations, and implanted pellets; the choice depends on goals, labs, lifestyle, and risk profile. The aim is not to push testosterone as high as possible — it is to return it to a healthy physiologic range, relieve the symptoms deficiency was causing, and stay safe over years, not weeks.¹

Replacement means physiologic levels

This distinction is crucial when interpreting safety claims. In TRAVERSE, the testosterone dose was adjusted to keep levels between 350 and 750 ng/dL, and treatment was stopped if a participant remained above 750 ng/dL on the lowest dose. The finding of no increase in major cardiovascular events applies to replacement within that physiologic target. It cannot be generalized to internet "TRT" protocols designed to maintain mildly or markedly supraphysiologic levels.³

Mildly supraphysiologic exposure may be far below what a competitive bodybuilder uses, but it is still not physiologic TRT. No randomized cardiovascular-outcomes trial has established whether that middle range increases, decreases, or leaves cardiovascular risk unchanged. Many testosterone effects are exposure-dependent: controlled dose-response data show progressively greater changes in muscle and fat-free mass, while hemoglobin and HDL cholesterol also change with dose and achieved concentration. Prospective data from men using anabolic-androgenic steroids likewise show increases in blood pressure, LDL cholesterol, apolipoprotein B, and hematocrit during use, but do not define a safe threshold or quantify long-term event risk for mildly supraphysiologic exposure.^10,12

The same principle matters in bodybuilding. More androgen is not automatically more useful. Some athletes may reach their stated body-composition or performance goal with substantially less exposure than common high-dose protocols, while many escalate far past what the goal requires and add risk without a proportional benefit. The harm-reduction principle is to use the lowest exposure consistent with the goal, avoid confusing escalation with optimization, and never confuse a lower nonmedical exposure with proven safety. This is not cycle design or an endorsement of supraphysiologic use.^10,12

The diagnosis comes first

The Endocrine Society's clinical practice guideline is explicit: hypogonadism should be diagnosed only in men with symptoms or signs of testosterone deficiency and unequivocally low testosterone, measured in the early morning, fasting, on at least two separate occasions.¹ A single afternoon level drawn during an illness, after a bad night of sleep, or during aggressive dieting is not a diagnosis — testosterone falls with all of those.

Measurement itself is a real problem. In a 2026 statement, the Endocrine Society reiterated that non-standardized assays mean the same blood sample can read "low" at one lab and "normal" at another, which is exactly why confirmation on repeat, standardized morning testing matters — with a common clinical threshold near 300 ng/dL, interpreted in context rather than as a magic line.²

Once low testosterone is confirmed, LH and FSH separate the two fundamentally different problems: primary hypogonadism, where the testes cannot produce enough testosterone, and secondary hypogonadism, where the signal from the pituitary and hypothalamus is reduced — sometimes by a treatable or reversible cause, occasionally by one (such as a prolactin-producing pituitary tumor) that must not be missed.¹

The symptoms — and why they are not enough

Low testosterone can produce low sex drive, fewer morning erections, erectile dysfunction, fatigue, low mood, reduced motivation, loss of muscle and strength, increased abdominal fat, lower bone density, and mild anemia. The sexual symptoms are the most specific; the rest overlap with half of general medicine.^1,5

In the European Male Ageing Study — the largest population study of its kind — genuine late-onset hypogonadism (symptoms plus low levels) was found in only about 2% of men aged 40 to 79, far fewer than the number reporting the symptoms alone.⁵ Poor sleep, sleep apnea, insulin resistance, thyroid disease, depression, overtraining, alcohol, opioids, and glucocorticoids all create the same picture. A clinic that asks only "do you feel tired?" is not diagnosing anything.

Important labs and checks before starting

A serious evaluation goes beyond a single total testosterone. Depending on the man, it typically includes: total testosterone (repeated, morning, fasting), free testosterone and SHBG when binding-protein issues are suspected, LH and FSH, estradiol, prolactin when indicated, a complete blood count with hematocrit, metabolic panel, A1c and fasting glucose, a lipid panel, thyroid testing when indicated, PSA in the appropriate age groups, and an honest assessment of sleep, medications, and alcohol.^1,9 The point is not to run every test on every man — it is to identify the pattern behind the number.

Who may consider treatment

Guidelines most strongly support TRT when a man has persistent symptoms consistent with deficiency, repeatedly low morning testosterone, and no contraindication. That is the group for whom the benefit-risk evidence is clearest; it is not a reason for reflexive gatekeeping when an informed adult has different goals or is already seriously considering testosterone. At Oriva, the conversation is individualized and candid: confirm what is driving the symptoms, define whether the goal is physiologic replacement or something beyond it, review fertility and cardiovascular risk, and use shared decision-making. When obesity is suppressing testosterone, weight loss remains first-line and can restore levels without replacement, but testosterone can still be discussed rather than dismissed automatically.^2,6 How hormones and weight interact in practice — including where GLP-1 medications fit — is a topic we cover separately in TRT and GLP-1 medications for men.

Who should not start

The guideline recommends against starting testosterone in men planning fertility in the near term, and in men with breast or prostate cancer, a palpable prostate nodule or significantly elevated PSA pending evaluation, an already-elevated hematocrit, untreated severe obstructive sleep apnea, severe lower urinary tract symptoms, uncontrolled heart failure, a heart attack or stroke within the last six months, or thrombophilia.¹ None of these are fine print. External testosterone shuts down the brain's signal to the testes, suppressing sperm production — men who want children soon need fertility-preserving alternatives discussed before the first dose, not after.

What TRT can do — and what it can't

In correctly diagnosed men, randomized trials show improvements in libido, sexual activity, and erectile function, modest improvements in mood and depressive symptoms, correction of unexplained anemia, and increased bone density and lean mass.^7,13,14 Libido and energy tend to respond within weeks; body composition and strength take months and depend heavily on resistance training, diet, and recovery — including sleep.

What TRT is not: a weight-loss drug, a cure for fatigue caused by sleep apnea, or a substitute for treating insulin resistance. If those drivers are present, testosterone alone will disappoint — and a clinic that promises otherwise is selling, not treating.

The risks, and what changed in 2025

Real risks include acne and oily skin, fluid retention, breast tenderness, worsening of untreated sleep apnea, testicular shrinkage and infertility, elevated estradiol, and a rise in red blood cell count (hematocrit) that increases blood viscosity — the most common lab reason to adjust therapy. On treatment, a hematocrit rising above roughly 54% warrants pausing or reducing the dose.^1,9

The cardiovascular question, which dominated this field for a decade, now has better data. TRAVERSE — a randomized trial of over 5,200 middle-aged and older men with hypogonadism and elevated cardiovascular risk — found no increase in major adverse cardiovascular events with testosterone versus placebo. But the dose was adjusted to a target of 350–750 ng/dL; this was physiologic replacement, not mildly or markedly supraphysiologic dosing.³ On that basis, the FDA removed the boxed-warning language about cardiovascular risk from all testosterone products in February 2025. The same review added a class-wide warning about increased blood pressure, based on ambulatory monitoring studies, and retained the "limitation of use" language for age-related low testosterone.⁴

Honesty requires the caveats too: in TRAVERSE and its substudies, testosterone-treated men had higher rates of pulmonary embolism, atrial fibrillation, acute kidney injury — and, unexpectedly, bone fractures.^3,8 These are secondary findings, not verdicts. Appropriate physiologic replacement with active monitoring has the strongest evidence; neither monitoring nor a normal result today guarantees safety, particularly above physiologic levels.

How treatment should be monitored

The guideline recommends evaluating symptoms, adverse effects, adherence, testosterone level, and hematocrit at 3 to 6 months after starting and then at least annually, with prostate risk assessment (PSA and examination in appropriate age groups) during the first year.¹ The best dose is not the highest dose. It is the one that resolves symptoms while keeping every safety marker in range — which is impossible to know without follow-up labs.

Stopping, fertility, and honest exits

TRT is not necessarily forever, but stopping is its own medical process: the suppressed hypothalamic-pituitary-testicular axis takes months to restart, and fertility recovery has its own timeline. We cover this in detail in Coming off TRT: restarting your own testosterone — and for men whose starting point was anabolic steroid use rather than prescribed therapy, in testosterone recovery after steroids.

Frequently asked questions

Is TRT safe?

For men with confirmed hypogonadism treated to physiologic levels, the best current evidence — including TRAVERSE — did not show increased major cardiovascular events. TRAVERSE targeted 350–750 ng/dL, so it does not establish safety for mildly or markedly supraphysiologic levels. Blood pressure, hematocrit, fertility, sleep apnea, and prostate risk still require active management.^3,4

Does TRT help with weight loss?

TRT is not a weight-loss medication. In men with true deficiency it can improve lean mass and body composition, but when obesity or insulin resistance is driving low testosterone, weight loss itself is first-line and often raises it. Greater aromatase activity in adipose tissue can convert more testosterone to estradiol, so added testosterone may cause estrogen-related effects such as breast tenderness, gynecomastia, or fluid retention and can complicate dosing. Evidence does not support treating estradiol itself as the reason fat loss stalls; in men, too little estradiol can promote fat accumulation.^2,6,11

Can TRT cause infertility?

Yes. External testosterone suppresses sperm production, sometimes profoundly. Men who want children in the near term should discuss fertility-preserving alternatives with a physician before starting.¹

How long does TRT take to work?

Libido and energy often improve within weeks. Muscle, strength, bone density, and body composition changes take months and depend on resistance training, diet, and recovery — including sleep.^7,14

Do I need labs before starting TRT?

Yes — the diagnosis requires symptoms plus consistently low testosterone on at least two early-morning, fasting measurements, ideally with LH and FSH to identify the cause. Symptom questionnaires alone are not a diagnosis.^1,2